Adam Sachs is the Co-Founder and CEO of Vicarious Surgical a next generation robotics company that is developing a disruptive medical technology platform. Their goal is to increase the efficiency of legacy surgical robotics, improving patient outcomes and reducing healthcare costs.
Vicarious Surgical's novel approach to surgery uses a combination of proprietary miniaturized surgical robots and virtual reality to transport surgeons inside the patient when performing minimally invasive surgery.
The first indication being targeted is ventral hernia repair for which Vicarious has been granted Breakthrough Device Special designthation from the FDA. The Vicarious system, with nine-degrees of freedom for each arm of the robot, can actually operate from inside of the abdomen out.
Surgeons are enthusiastic about the ability to work facing any direction from any incision site.